Skip to content
Agentic OS
Menu

Intelligence / B2B SaaS / Acquisitions / Mangoceuticals, INC.

M&Asold assets or a business (SEC 8-K)1 Oct 2026

Mangoceuticals, INC.

1 Oct 2026: Sold assets or a business (SEC 8-K) · Health services. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
1 Oct 2026
Ticker
MGRX
Role
Sold assets or a business
Sector
Health services
Sic
8090
Items
1.01, 2.01, 3.02, 7.01, 9.01
Summary
To the extent that the sale of the 25% ownership interest in MangoRx IP constituted or will constitute a significant disposition for purposes of
Location
Dallas, TX
State
Texas
Country
United States
SEC CIK
1938046
Reference
0001493152-26-045341
What this signal means

Integration means consolidating tools and vendors: the buyer re-platforms the target, and an acquired company's stack is reviewed by its new owner.

  1. Completed an acquisition leads with 189 of 292, then Sold assets or a business (82).
  2. 103 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at Mangoceuticals, INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this m&a signal, for your approval.

Start free

More in Sold assets or a business

Acquisitions

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 2.01 (completion of an acquisition or disposition of assets) filed with the SEC in the last 90 days. The role (buyer, company acquired, seller) is read from the filing's own wording, which is quoted on each row. AOS shows what the public record says; it does not verify or endorse the company.